

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | modulation by virus of host process (GO:0019054) | 8.80609004 |
| 2 | detection of calcium ion (GO:0005513) | 8.42527695 |
| 3 | modulation by symbiont of host cellular process (GO:0044068) | 6.94574652 |
| 4 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 6.84453505 |
| 5 | negative regulation of catenin import into nucleus (GO:0035414) | 6.16487345 |
| 6 | sensory perception of smell (GO:0007608) | 5.66643513 |
| 7 | layer formation in cerebral cortex (GO:0021819) | 5.18638522 |
| 8 | neuronal action potential (GO:0019228) | 5.12997776 |
| 9 | cellular response to virus (GO:0098586) | 5.02835909 |
| 10 | nerve growth factor signaling pathway (GO:0038180) | 5.01635270 |
| 11 | response to auditory stimulus (GO:0010996) | 4.98153136 |
| 12 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 4.83604196 |
| 13 | exploration behavior (GO:0035640) | 4.81575746 |
| 14 | cellular response to glucagon stimulus (GO:0071377) | 4.80408035 |
| 15 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.61854584 |
| 16 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 4.59319880 |
| 17 | positive regulation of synapse maturation (GO:0090129) | 4.55902051 |
| 18 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 4.55060112 |
| 19 | negative regulation of execution phase of apoptosis (GO:1900118) | 4.54632076 |
| 20 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 4.48498698 |
| 21 | venous blood vessel morphogenesis (GO:0048845) | 4.42055007 |
| 22 | modulation by virus of host morphology or physiology (GO:0019048) | 4.40790311 |
| 23 | dopamine receptor signaling pathway (GO:0007212) | 4.32207850 |
| 24 | sensory perception of chemical stimulus (GO:0007606) | 4.30599088 |
| 25 | morphogenesis of an endothelium (GO:0003159) | 4.30332415 |
| 26 | endothelial tube morphogenesis (GO:0061154) | 4.30332415 |
| 27 | protein insertion into membrane (GO:0051205) | 4.28805590 |
| 28 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.18402221 |
| 29 | regulation of ARF protein signal transduction (GO:0032012) | 4.12787420 |
| 30 | negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948) | 4.11845411 |
| 31 | protein localization to cilium (GO:0061512) | 4.10018195 |
| 32 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.98774893 |
| 33 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.86973084 |
| 34 | pericardium development (GO:0060039) | 3.86044974 |
| 35 | regulation of synapse structural plasticity (GO:0051823) | 3.85227514 |
| 36 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.83951467 |
| 37 | regulation of telomere maintenance via telomerase (GO:0032210) | 3.82465280 |
| 38 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 3.78308800 |
| 39 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.78114614 |
| 40 | mating behavior (GO:0007617) | 3.76092755 |
| 41 | neuron cell-cell adhesion (GO:0007158) | 3.75977790 |
| 42 | regulation of synapse maturation (GO:0090128) | 3.74998087 |
| 43 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.72146415 |
| 44 | neurotransmitter secretion (GO:0007269) | 3.71975332 |
| 45 | synaptic vesicle maturation (GO:0016188) | 3.70171961 |
| 46 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.69205444 |
| 47 | positive regulation of dendritic spine development (GO:0060999) | 3.68239076 |
| 48 | vocalization behavior (GO:0071625) | 3.61010725 |
| 49 | prepulse inhibition (GO:0060134) | 3.60531221 |
| 50 | regulation of protein targeting to membrane (GO:0090313) | 3.58925714 |
| 51 | cerebellar granule cell differentiation (GO:0021707) | 3.57362698 |
| 52 | neuromuscular process controlling posture (GO:0050884) | 3.55662214 |
| 53 | neuronal ion channel clustering (GO:0045161) | 3.55244090 |
| 54 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.53815891 |
| 55 | positive regulation of membrane potential (GO:0045838) | 3.53450189 |
| 56 | positive regulation of Rap GTPase activity (GO:0032854) | 3.52499955 |
| 57 | dendritic spine morphogenesis (GO:0060997) | 3.50789146 |
| 58 | locomotory exploration behavior (GO:0035641) | 3.49973800 |
| 59 | response to glucagon (GO:0033762) | 3.49241289 |
| 60 | response to muramyl dipeptide (GO:0032495) | 3.44568724 |
| 61 | cellular response to prostaglandin stimulus (GO:0071379) | 3.43910485 |
| 62 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.43788755 |
| 63 | regulation of Rap GTPase activity (GO:0032317) | 3.42327580 |
| 64 | cAMP catabolic process (GO:0006198) | 3.38733142 |
| 65 | axonal fasciculation (GO:0007413) | 3.36108194 |
| 66 | iron-sulfur cluster assembly (GO:0016226) | 3.34218776 |
| 67 | metallo-sulfur cluster assembly (GO:0031163) | 3.34218776 |
| 68 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.28467022 |
| 69 | neuron recognition (GO:0008038) | 3.28408230 |
| 70 | response to amphetamine (GO:0001975) | 3.28023297 |
| 71 | cell differentiation in hindbrain (GO:0021533) | 3.26998748 |
| 72 | auditory behavior (GO:0031223) | 3.26661823 |
| 73 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.24484975 |
| 74 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.23983771 |
| 75 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.21863237 |
| 76 | synaptic vesicle exocytosis (GO:0016079) | 3.19464382 |
| 77 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.19379340 |
| 78 | mitochondrion transport along microtubule (GO:0047497) | 3.16582071 |
| 79 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 3.16582071 |
| 80 | regulation of neurotransmitter secretion (GO:0046928) | 3.14626128 |
| 81 | Peyers patch development (GO:0048541) | 3.14614329 |
| 82 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.14614329 |
| 83 | microtubule bundle formation (GO:0001578) | 3.14018370 |
| 84 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.13197949 |
| 85 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.11395970 |
| 86 | striatum development (GO:0021756) | 3.10467563 |
| 87 | cellular potassium ion homeostasis (GO:0030007) | 3.09973455 |
| 88 | establishment of mitochondrion localization (GO:0051654) | 3.09015795 |
| 89 | ADP metabolic process (GO:0046031) | 3.08908199 |
| 90 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.07848181 |
| 91 | activation of MAPKKK activity (GO:0000185) | 3.06817881 |
| 92 | synaptic transmission, dopaminergic (GO:0001963) | 3.06693818 |
| 93 | glutamate secretion (GO:0014047) | 3.03101409 |
| 94 | cyclic nucleotide catabolic process (GO:0009214) | 3.00295535 |
| 95 | neurofilament cytoskeleton organization (GO:0060052) | 3.00275888 |
| 96 | synaptic vesicle endocytosis (GO:0048488) | 2.99783077 |
| 97 | regulation of synaptic plasticity (GO:0048167) | 2.99196651 |
| 98 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.99132852 |
| 99 | response to peptidoglycan (GO:0032494) | 2.98345048 |
| 100 | behavioral response to cocaine (GO:0048148) | 2.97107200 |
| 101 | cell migration in hindbrain (GO:0021535) | 2.96809571 |
| 102 | response to nerve growth factor (GO:1990089) | 2.96135084 |
| 103 | cellular response to nerve growth factor stimulus (GO:1990090) | 2.96135084 |
| 104 | regulation of protein kinase A signaling (GO:0010738) | 2.95637807 |
| 105 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.95341695 |
| 106 | negative regulation of anoikis (GO:2000811) | 2.94490712 |
| 107 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.93164912 |
| 108 | neurotransmitter transport (GO:0006836) | 2.92976860 |
| 109 | sensory perception of taste (GO:0050909) | 2.92080920 |
| 110 | regulation of G0 to G1 transition (GO:0070316) | 2.90499915 |
| 111 | positive regulation of neurotransmitter transport (GO:0051590) | 2.90459781 |
| 112 | neuronal action potential propagation (GO:0019227) | 2.86152234 |
| 113 | response to gravity (GO:0009629) | 2.86081787 |
| 114 | serotonin metabolic process (GO:0042428) | 2.85995372 |
| 115 | regulation of synaptic vesicle transport (GO:1902803) | 2.85258435 |
| 116 | postsynaptic membrane organization (GO:0001941) | 2.85221061 |
| 117 | glutathione biosynthetic process (GO:0006750) | 2.84943147 |
| 118 | snRNA transcription (GO:0009301) | 2.82857432 |
| 119 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.82788775 |
| 120 | long-term memory (GO:0007616) | 2.81862952 |
| 121 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.81170467 |
| 122 | neuromuscular process controlling balance (GO:0050885) | 2.80843660 |
| 123 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.80692542 |
| 124 | regulation of regulated secretory pathway (GO:1903305) | 2.80070564 |
| 125 | Rap protein signal transduction (GO:0032486) | 2.79751260 |
| 126 | activation of protein kinase A activity (GO:0034199) | 2.79523134 |
| 127 | protein localization to synapse (GO:0035418) | 2.79462600 |
| 128 | action potential (GO:0001508) | 2.79064753 |
| 129 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.78553688 |
| 130 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.77542382 |
| 131 | synaptic transmission, glutamatergic (GO:0035249) | 2.77504936 |
| 132 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.76573909 |
| 133 | regulation of respiratory gaseous exchange (GO:0043576) | 2.76011891 |
| 134 | release of cytochrome c from mitochondria (GO:0001836) | 2.75402604 |
| 135 | negative regulation of Ras GTPase activity (GO:0034261) | 2.74190547 |
| 136 | cellular response to monoamine stimulus (GO:0071868) | 2.74075447 |
| 137 | cellular response to catecholamine stimulus (GO:0071870) | 2.74075447 |
| 138 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.73124702 |
| 139 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.72617181 |
| 140 | regulation of gamma-delta T cell activation (GO:0046643) | 2.70076594 |
| 141 | germinal center formation (GO:0002467) | 2.69618197 |
| 142 | negative regulation of interleukin-12 production (GO:0032695) | 2.67882053 |
| 143 | regulation of glycogen (starch) synthase activity (GO:2000465) | 2.66452907 |
| 144 | histone H3-K4 trimethylation (GO:0080182) | 2.65304486 |
| 145 | regulation of neurotransmitter transport (GO:0051588) | 2.64389405 |
| 146 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.60657622 |
| 147 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.60269123 |
| 148 | regulation of postsynaptic membrane potential (GO:0060078) | 2.58578402 |
| 149 | chemosensory behavior (GO:0007635) | 2.58019295 |
| 150 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.57770898 |
| 151 | glucocorticoid receptor signaling pathway (GO:0042921) | 2.56369115 |
| 152 | regulation of neurotransmitter levels (GO:0001505) | 2.55774425 |
| 153 | regulation of respiratory system process (GO:0044065) | 2.54846099 |
| 154 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.54620917 |
| 155 | membrane depolarization during action potential (GO:0086010) | 2.54074886 |
| 156 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.53747859 |
| 157 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.53720537 |
| 158 | proline transport (GO:0015824) | 2.53097612 |
| 159 | neuron-neuron synaptic transmission (GO:0007270) | 2.49677145 |
| 160 | neutrophil activation (GO:0042119) | 2.48841445 |
| 161 | regulation of synaptic transmission (GO:0050804) | 2.44087348 |
| 162 | primary amino compound metabolic process (GO:1901160) | 2.43452250 |
| 163 | regulation of telomerase activity (GO:0051972) | 2.43400811 |
| 164 | response to manganese ion (GO:0010042) | 2.42747563 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.84581041 |
| 2 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 4.98899095 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.41427185 |
| 4 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.58860000 |
| 5 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 3.28969798 |
| 6 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 3.28210452 |
| 7 | MYC_22102868_ChIP-Seq_BL_Human | 3.01479831 |
| 8 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.88564640 |
| 9 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.69165218 |
| 10 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.64421558 |
| 11 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.54424811 |
| 12 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.51318064 |
| 13 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.51318064 |
| 14 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.51291105 |
| 15 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.48700180 |
| 16 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.45677295 |
| 17 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.38687686 |
| 18 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.34581617 |
| 19 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.22591387 |
| 20 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.19603391 |
| 21 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.18633062 |
| 22 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.17386124 |
| 23 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.15858578 |
| 24 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.14915463 |
| 25 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.13377948 |
| 26 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.12241970 |
| 27 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.11994436 |
| 28 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.10852585 |
| 29 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.10752401 |
| 30 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.07118390 |
| 31 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.02978524 |
| 32 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.99253568 |
| 33 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.97102850 |
| 34 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.91053196 |
| 35 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.90536579 |
| 36 | KDM2B_26808549_Chip-Seq_K562_Human | 1.89183443 |
| 37 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.85190612 |
| 38 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.81222514 |
| 39 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.78581158 |
| 40 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.78384882 |
| 41 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.78366935 |
| 42 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.78165236 |
| 43 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.76097012 |
| 44 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.72925707 |
| 45 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.63112033 |
| 46 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.62233582 |
| 47 | * MAF_26560356_Chip-Seq_TH1_Human | 1.61603091 |
| 48 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.60184771 |
| 49 | P68_20966046_ChIP-Seq_HELA_Human | 1.59051881 |
| 50 | SPI1_23127762_ChIP-Seq_K562_Human | 1.53660863 |
| 51 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.53545284 |
| 52 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.52644414 |
| 53 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.51487526 |
| 54 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.49437731 |
| 55 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.44405132 |
| 56 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.40163799 |
| 57 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.40016489 |
| 58 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.39811822 |
| 59 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.39669078 |
| 60 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.38310426 |
| 61 | UTX_26944678_Chip-Seq_JUKART_Human | 1.36947694 |
| 62 | SA1_27219007_Chip-Seq_Bcells_Human | 1.34196756 |
| 63 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.31454390 |
| 64 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.29695010 |
| 65 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.29067744 |
| 66 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.28915205 |
| 67 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.28537071 |
| 68 | MAF_26560356_Chip-Seq_TH2_Human | 1.27980829 |
| 69 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.27627287 |
| 70 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.26979307 |
| 71 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.26175578 |
| 72 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.25807811 |
| 73 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.24751258 |
| 74 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.23498501 |
| 75 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.23145098 |
| 76 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.21519130 |
| 77 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21406090 |
| 78 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.20334218 |
| 79 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.18762341 |
| 80 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.18322700 |
| 81 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.18124030 |
| 82 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.17040978 |
| 83 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.16256718 |
| 84 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.15118043 |
| 85 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.14149746 |
| 86 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.13959006 |
| 87 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.12682882 |
| 88 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.11100956 |
| 89 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.10894854 |
| 90 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.09973867 |
| 91 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.09835238 |
| 92 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.09594264 |
| 93 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.09215758 |
| 94 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.09101013 |
| 95 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08715320 |
| 96 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.07499906 |
| 97 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.06237248 |
| 98 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.04251435 |
| 99 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.03876890 |
| 100 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.03800455 |
| 101 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.03346115 |
| 102 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.02541363 |
| 103 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.01904530 |
| 104 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.00687099 |
| 105 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 1.00457227 |
| 106 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.99821756 |
| 107 | AR_19668381_ChIP-Seq_PC3_Human | 0.98297143 |
| 108 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.97772269 |
| 109 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97646088 |
| 110 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.97428725 |
| 111 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.97170218 |
| 112 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.97142333 |
| 113 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.96553919 |
| 114 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.96395280 |
| 115 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.95658376 |
| 116 | GATA1_19941826_ChIP-Seq_K562_Human | 0.95542004 |
| 117 | E2F7_22180533_ChIP-Seq_HELA_Human | 0.95413317 |
| 118 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.95231333 |
| 119 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.95118094 |
| 120 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.95050768 |
| 121 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.93624165 |
| 122 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.93388089 |
| 123 | * KLF4_19829295_ChIP-Seq_ESCs_Human | 0.92179112 |
| 124 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.92134523 |
| 125 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.91883591 |
| 126 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.91840987 |
| 127 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.91624059 |
| 128 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.91347151 |
| 129 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.89445170 |
| 130 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.89445170 |
| 131 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.88404803 |
| 132 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.88342075 |
| 133 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.86502837 |
| 134 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.86360280 |
| 135 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.85313016 |
| 136 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.83626936 |
| 137 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.83241237 |
| 138 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.81363172 |
| 139 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.81309220 |
| 140 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 0.80860784 |
| 141 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.80219915 |
| 142 | RUNX1_26923725_Chip-Seq_HPCs_Mouse | 0.79908563 |
| 143 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.78227713 |
| 144 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.77585747 |
| 145 | P300_19829295_ChIP-Seq_ESCs_Human | 0.76947710 |
| 146 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.76792284 |
| 147 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.76544964 |
| 148 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.75653297 |
| 149 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.75398067 |
| 150 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.75370240 |
| 151 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.74768941 |
| 152 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.74042351 |
| 153 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.74034362 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001984_abnormal_olfaction | 5.76248662 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 5.47849722 |
| 3 | MP0002822_catalepsy | 4.76733876 |
| 4 | MP0003878_abnormal_ear_physiology | 3.77551281 |
| 5 | MP0005377_hearing/vestibular/ear_phenot | 3.77551281 |
| 6 | MP0004270_analgesia | 3.67573148 |
| 7 | MP0003635_abnormal_synaptic_transmissio | 3.47020471 |
| 8 | MP0003880_abnormal_central_pattern | 3.25369316 |
| 9 | MP0004858_abnormal_nervous_system | 3.00041876 |
| 10 | MP0002063_abnormal_learning/memory/cond | 2.82596627 |
| 11 | MP0009745_abnormal_behavioral_response | 2.72164759 |
| 12 | MP0003787_abnormal_imprinting | 2.69542100 |
| 13 | MP0005645_abnormal_hypothalamus_physiol | 2.64990932 |
| 14 | MP0001348_abnormal_lacrimal_gland | 2.64769197 |
| 15 | MP0001486_abnormal_startle_reflex | 2.60247019 |
| 16 | MP0005423_abnormal_somatic_nervous | 2.53636416 |
| 17 | MP0005499_abnormal_olfactory_system | 2.50234660 |
| 18 | MP0005394_taste/olfaction_phenotype | 2.50234660 |
| 19 | MP0002064_seizures | 2.38449568 |
| 20 | MP0002572_abnormal_emotion/affect_behav | 2.35415944 |
| 21 | MP0001485_abnormal_pinna_reflex | 2.32429394 |
| 22 | MP0000015_abnormal_ear_pigmentation | 2.32046039 |
| 23 | MP0005646_abnormal_pituitary_gland | 2.25339278 |
| 24 | MP0009278_abnormal_bone_marrow | 2.24306070 |
| 25 | MP0003303_peritoneal_inflammation | 2.14606223 |
| 26 | MP0008789_abnormal_olfactory_epithelium | 2.13133037 |
| 27 | MP0003436_decreased_susceptibility_to | 2.08207443 |
| 28 | MP0005451_abnormal_body_composition | 2.06935909 |
| 29 | MP0008877_abnormal_DNA_methylation | 2.05067562 |
| 30 | MP0002272_abnormal_nervous_system | 2.04165549 |
| 31 | MP0003724_increased_susceptibility_to | 1.94831878 |
| 32 | MP0002184_abnormal_innervation | 1.93652530 |
| 33 | MP0009046_muscle_twitch | 1.92731676 |
| 34 | MP0004510_myositis | 1.92019189 |
| 35 | MP0003646_muscle_fatigue | 1.89826019 |
| 36 | MP0000778_abnormal_nervous_system | 1.85358010 |
| 37 | MP0010386_abnormal_urinary_bladder | 1.84721946 |
| 38 | MP0001529_abnormal_vocalization | 1.81941560 |
| 39 | MP0004811_abnormal_neuron_physiology | 1.75618350 |
| 40 | MP0005167_abnormal_blood-brain_barrier | 1.72552738 |
| 41 | MP0002557_abnormal_social/conspecific_i | 1.72321139 |
| 42 | MP0001968_abnormal_touch/_nociception | 1.71134270 |
| 43 | MP0005000_abnormal_immune_tolerance | 1.69813719 |
| 44 | MP0002734_abnormal_mechanical_nocicepti | 1.67985095 |
| 45 | MP0003123_paternal_imprinting | 1.61905874 |
| 46 | MP0010352_gastrointestinal_tract_polyps | 1.54773173 |
| 47 | MP0004130_abnormal_muscle_cell | 1.51970588 |
| 48 | MP0004185_abnormal_adipocyte_glucose | 1.51124593 |
| 49 | MP0002735_abnormal_chemical_nociception | 1.48956969 |
| 50 | MP0002882_abnormal_neuron_morphology | 1.47570678 |
| 51 | MP0006276_abnormal_autonomic_nervous | 1.47539565 |
| 52 | MP0001970_abnormal_pain_threshold | 1.46102944 |
| 53 | MP0002160_abnormal_reproductive_system | 1.43942974 |
| 54 | MP0001905_abnormal_dopamine_level | 1.40675339 |
| 55 | MP0002152_abnormal_brain_morphology | 1.36196460 |
| 56 | MP0004233_abnormal_muscle_weight | 1.34490138 |
| 57 | MP0003329_amyloid_beta_deposits | 1.33493964 |
| 58 | MP0003172_abnormal_lysosome_physiology | 1.31022995 |
| 59 | MP0002723_abnormal_immune_serum | 1.30588480 |
| 60 | MP0002909_abnormal_adrenal_gland | 1.29604523 |
| 61 | MP0005310_abnormal_salivary_gland | 1.29403345 |
| 62 | MP0001800_abnormal_humoral_immune | 1.24696099 |
| 63 | MP0005671_abnormal_response_to | 1.24116915 |
| 64 | MP0002148_abnormal_hypersensitivity_rea | 1.22025358 |
| 65 | MP0002420_abnormal_adaptive_immunity | 1.22012979 |
| 66 | MP0005025_abnormal_response_to | 1.21982312 |
| 67 | MP0002067_abnormal_sensory_capabilities | 1.21781211 |
| 68 | MP0003075_altered_response_to | 1.19908297 |
| 69 | MP0001819_abnormal_immune_cell | 1.19618436 |
| 70 | MP0001501_abnormal_sleep_pattern | 1.18844920 |
| 71 | MP0005623_abnormal_meninges_morphology | 1.16442196 |
| 72 | MP0005076_abnormal_cell_differentiation | 1.15719564 |
| 73 | MP0005386_behavior/neurological_phenoty | 1.15032980 |
| 74 | MP0004924_abnormal_behavior | 1.15032980 |
| 75 | MP0000003_abnormal_adipose_tissue | 1.14715329 |
| 76 | MP0001835_abnormal_antigen_presentation | 1.14196416 |
| 77 | MP0002398_abnormal_bone_marrow | 1.14050206 |
| 78 | MP0008569_lethality_at_weaning | 1.13522640 |
| 79 | MP0002452_abnormal_antigen_presenting | 1.12911809 |
| 80 | MP0005387_immune_system_phenotype | 1.11062634 |
| 81 | MP0001790_abnormal_immune_system | 1.11062634 |
| 82 | MP0001188_hyperpigmentation | 1.10502564 |
| 83 | MP0003763_abnormal_thymus_physiology | 1.10111820 |
| 84 | MP0002733_abnormal_thermal_nociception | 1.09954434 |
| 85 | MP0002066_abnormal_motor_capabilities/c | 1.09317496 |
| 86 | MP0002419_abnormal_innate_immunity | 1.08735959 |
| 87 | MP0000013_abnormal_adipose_tissue | 1.08734685 |
| 88 | MP0009333_abnormal_splenocyte_physiolog | 1.07858483 |
| 89 | MP0000685_abnormal_immune_system | 1.07099929 |
| 90 | MP0002127_abnormal_cardiovascular_syste | 1.06483885 |
| 91 | MP0001502_abnormal_circadian_rhythm | 1.04675364 |
| 92 | MP0000955_abnormal_spinal_cord | 1.04646002 |
| 93 | MP0000537_abnormal_urethra_morphology | 1.01967866 |
| 94 | MP0001963_abnormal_hearing_physiology | 1.01659019 |
| 95 | MP0002752_abnormal_somatic_nervous | 1.00450754 |
| 96 | MP0000716_abnormal_immune_system | 1.00104521 |
| 97 | MP0000678_abnormal_parathyroid_gland | 0.98524207 |
| 98 | MP0004782_abnormal_surfactant_physiolog | 0.97750157 |
| 99 | MP0003631_nervous_system_phenotype | 0.95503553 |
| 100 | MP0008961_abnormal_basal_metabolism | 0.95093763 |
| 101 | MP0000569_abnormal_digit_pigmentation | 0.94993491 |
| 102 | MP0004885_abnormal_endolymph | 0.94403373 |
| 103 | MP0000604_amyloidosis | 0.93618132 |
| 104 | MP0005397_hematopoietic_system_phenotyp | 0.93529767 |
| 105 | MP0001545_abnormal_hematopoietic_system | 0.93529767 |
| 106 | MP0002069_abnormal_eating/drinking_beha | 0.91178971 |
| 107 | MP0000631_abnormal_neuroendocrine_gland | 0.90555649 |
| 108 | MP0008874_decreased_physiological_sensi | 0.89847972 |
| 109 | MP0003252_abnormal_bile_duct | 0.87796914 |
| 110 | MP0000026_abnormal_inner_ear | 0.86930753 |
| 111 | MP0001533_abnormal_skeleton_physiology | 0.86676513 |
| 112 | MP0002229_neurodegeneration | 0.86185407 |
| 113 | MP0003879_abnormal_hair_cell | 0.86092647 |
| 114 | MP0003861_abnormal_nervous_system | 0.85291988 |
| 115 | MP0009785_altered_susceptibility_to | 0.84126702 |
| 116 | MP0002736_abnormal_nociception_after | 0.82565019 |
| 117 | MP0003195_calcinosis | 0.81879226 |
| 118 | MP0002653_abnormal_ependyma_morphology | 0.81335768 |
| 119 | MP0002429_abnormal_blood_cell | 0.79219662 |
| 120 | MP0000751_myopathy | 0.77503125 |
| 121 | MP0004742_abnormal_vestibular_system | 0.76297578 |
| 122 | MP0003121_genomic_imprinting | 0.76058193 |
| 123 | MP0005171_absent_coat_pigmentation | 0.75564564 |
| 124 | MP0000703_abnormal_thymus_morphology | 0.74484246 |
| 125 | MP0002722_abnormal_immune_system | 0.74333307 |
| 126 | MP0003283_abnormal_digestive_organ | 0.74010739 |
| 127 | MP0008872_abnormal_physiological_respon | 0.73265767 |
| 128 | MP0009764_decreased_sensitivity_to | 0.72545358 |
| 129 | MP0000467_abnormal_esophagus_morphology | 0.72150511 |
| 130 | MP0002163_abnormal_gland_morphology | 0.71200852 |
| 131 | MP0001845_abnormal_inflammatory_respons | 0.71070814 |
| 132 | MP0000920_abnormal_myelination | 0.70768070 |
| 133 | MP0000689_abnormal_spleen_morphology | 0.69944034 |
| 134 | MP0002928_abnormal_bile_duct | 0.68574866 |
| 135 | MP0002638_abnormal_pupillary_reflex | 0.68508067 |
| 136 | MP0001440_abnormal_grooming_behavior | 0.67201470 |
| 137 | MP0002095_abnormal_skin_pigmentation | 0.66986102 |
| 138 | MP0003045_fibrosis | 0.66443364 |
| 139 | MP0003633_abnormal_nervous_system | 0.66024273 |
| 140 | MP0001177_atelectasis | 0.65384641 |
| 141 | MP0009780_abnormal_chondrocyte_physiolo | 0.61630070 |
| 142 | MP0003632_abnormal_nervous_system | 0.60930694 |
| 143 | MP0005535_abnormal_body_temperature | 0.60813610 |
| 144 | MP0003634_abnormal_glial_cell | 0.59763488 |
| 145 | MP0002081_perinatal_lethality | 0.58841782 |
| 146 | MP0003122_maternal_imprinting | 0.58547671 |
| 147 | MP0005187_abnormal_penis_morphology | 0.54463740 |
| 148 | MP0000538_abnormal_urinary_bladder | 0.54038750 |
| 149 | MP0000534_abnormal_ureter_morphology | 0.53005963 |
| 150 | MP0002082_postnatal_lethality | 0.52863282 |
| 151 | MP0010770_preweaning_lethality | 0.52863282 |
| 152 | MP0003690_abnormal_glial_cell | 0.51647199 |
| 153 | MP0001943_abnormal_respiration | 0.51416809 |
| 154 | MP0004085_abnormal_heartbeat | 0.51336932 |
| 155 | MP0001186_pigmentation_phenotype | 0.51183333 |
| 156 | MP0010769_abnormal_survival | 0.51079471 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 6.11875531 |
| 2 | Focal seizures (HP:0007359) | 4.60840104 |
| 3 | Limb dystonia (HP:0002451) | 4.56795650 |
| 4 | Focal motor seizures (HP:0011153) | 4.52157820 |
| 5 | Scanning speech (HP:0002168) | 4.43208402 |
| 6 | Ankle clonus (HP:0011448) | 3.94517928 |
| 7 | Febrile seizures (HP:0002373) | 3.90367528 |
| 8 | Truncal ataxia (HP:0002078) | 3.80398549 |
| 9 | Torticollis (HP:0000473) | 3.79884285 |
| 10 | Anosmia (HP:0000458) | 3.61308893 |
| 11 | Retinal dysplasia (HP:0007973) | 3.53253180 |
| 12 | Atonic seizures (HP:0010819) | 3.29293315 |
| 13 | Segmental peripheral demyelination/remyelination (HP:0003481) | 3.28387258 |
| 14 | Focal dystonia (HP:0004373) | 3.20398866 |
| 15 | Optic neuritis (HP:0100653) | 3.14756853 |
| 16 | Retrobulbar optic neuritis (HP:0100654) | 3.14756853 |
| 17 | Broad-based gait (HP:0002136) | 3.11094759 |
| 18 | Craniofacial dystonia (HP:0012179) | 3.09609444 |
| 19 | Poor eye contact (HP:0000817) | 3.08616311 |
| 20 | Postural instability (HP:0002172) | 3.06765703 |
| 21 | Polygenic inheritance (HP:0010982) | 3.03677958 |
| 22 | Abnormal hair whorl (HP:0010721) | 3.01783798 |
| 23 | Narrow nasal bridge (HP:0000446) | 3.00488621 |
| 24 | Diplopia (HP:0000651) | 2.98238383 |
| 25 | Abnormality of binocular vision (HP:0011514) | 2.98238383 |
| 26 | Pointed chin (HP:0000307) | 2.95837196 |
| 27 | Hyperventilation (HP:0002883) | 2.92634437 |
| 28 | Neoplasm of the adrenal cortex (HP:0100641) | 2.86606331 |
| 29 | Cerebral aneurysm (HP:0004944) | 2.85470928 |
| 30 | Orchitis (HP:0100796) | 2.82458694 |
| 31 | Insomnia (HP:0100785) | 2.76821919 |
| 32 | Fetal akinesia sequence (HP:0001989) | 2.74640745 |
| 33 | Visual hallucinations (HP:0002367) | 2.72976360 |
| 34 | Abnormality of the diencephalon (HP:0010662) | 2.72765409 |
| 35 | Clonus (HP:0002169) | 2.72581238 |
| 36 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.70151049 |
| 37 | Inability to walk (HP:0002540) | 2.67609759 |
| 38 | Stereotypic behavior (HP:0000733) | 2.66360679 |
| 39 | Generalized tonic-clonic seizures (HP:0002069) | 2.66236845 |
| 40 | Dysphonia (HP:0001618) | 2.63449534 |
| 41 | Bowel diverticulosis (HP:0005222) | 2.63182780 |
| 42 | Abnormal social behavior (HP:0012433) | 2.63037963 |
| 43 | Impaired social interactions (HP:0000735) | 2.63037963 |
| 44 | Peripheral hypomyelination (HP:0007182) | 2.62250438 |
| 45 | Epileptic encephalopathy (HP:0200134) | 2.60287705 |
| 46 | Absence seizures (HP:0002121) | 2.58210458 |
| 47 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.54177396 |
| 48 | Elfin facies (HP:0004428) | 2.50857334 |
| 49 | Gait imbalance (HP:0002141) | 2.50465913 |
| 50 | Neuronal loss in central nervous system (HP:0002529) | 2.49852661 |
| 51 | High anterior hairline (HP:0009890) | 2.49446848 |
| 52 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.49069223 |
| 53 | Increased cerebral lipofuscin (HP:0011813) | 2.45982013 |
| 54 | Septate vagina (HP:0001153) | 2.44516083 |
| 55 | Dysmetria (HP:0001310) | 2.44041131 |
| 56 | Specific learning disability (HP:0001328) | 2.43417407 |
| 57 | Syncope (HP:0001279) | 2.40628080 |
| 58 | Exotropia (HP:0000577) | 2.40197922 |
| 59 | Renovascular hypertension (HP:0100817) | 2.40066879 |
| 60 | Hypoplasia of the iris (HP:0007676) | 2.38531085 |
| 61 | Polyphagia (HP:0002591) | 2.34561727 |
| 62 | Impaired smooth pursuit (HP:0007772) | 2.31916970 |
| 63 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.31910352 |
| 64 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.31910352 |
| 65 | Tetraplegia (HP:0002445) | 2.31240397 |
| 66 | Abnormal ciliary motility (HP:0012262) | 2.29993865 |
| 67 | Spinal canal stenosis (HP:0003416) | 2.27623676 |
| 68 | Sleep apnea (HP:0010535) | 2.25665379 |
| 69 | Annular pancreas (HP:0001734) | 2.23674124 |
| 70 | Blue irides (HP:0000635) | 2.23316413 |
| 71 | Hyperacusis (HP:0010780) | 2.22997858 |
| 72 | Bradykinesia (HP:0002067) | 2.22919014 |
| 73 | Myositis (HP:0100614) | 2.20943433 |
| 74 | Status epilepticus (HP:0002133) | 2.20552896 |
| 75 | Amblyopia (HP:0000646) | 2.20234852 |
| 76 | Supranuclear gaze palsy (HP:0000605) | 2.20036304 |
| 77 | Methylmalonic acidemia (HP:0002912) | 2.20026431 |
| 78 | Depression (HP:0000716) | 2.19206870 |
| 79 | Action tremor (HP:0002345) | 2.19108321 |
| 80 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.17473278 |
| 81 | Urinary urgency (HP:0000012) | 2.17063753 |
| 82 | Gastrointestinal stroma tumor (HP:0100723) | 2.15696093 |
| 83 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.15633339 |
| 84 | Abnormal eating behavior (HP:0100738) | 2.14673006 |
| 85 | Dialeptic seizures (HP:0011146) | 2.14493295 |
| 86 | Abnormality of homocysteine metabolism (HP:0010919) | 2.13854116 |
| 87 | Homocystinuria (HP:0002156) | 2.13854116 |
| 88 | Medial flaring of the eyebrow (HP:0010747) | 2.13471806 |
| 89 | Cystic liver disease (HP:0006706) | 2.13358037 |
| 90 | Bundle branch block (HP:0011710) | 2.12884664 |
| 91 | Obstructive sleep apnea (HP:0002870) | 2.12733249 |
| 92 | Abnormality of the lower motor neuron (HP:0002366) | 2.12724788 |
| 93 | Autoimmune thrombocytopenia (HP:0001973) | 2.10988555 |
| 94 | Congenital primary aphakia (HP:0007707) | 2.10461333 |
| 95 | Gaze-evoked nystagmus (HP:0000640) | 2.10371765 |
| 96 | Dysmetric saccades (HP:0000641) | 2.08511696 |
| 97 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.08113158 |
| 98 | Excessive salivation (HP:0003781) | 2.07882615 |
| 99 | Drooling (HP:0002307) | 2.07882615 |
| 100 | Absent speech (HP:0001344) | 2.06554922 |
| 101 | Sudden death (HP:0001699) | 2.04453653 |
| 102 | Lower limb muscle weakness (HP:0007340) | 2.03648929 |
| 103 | Stroke (HP:0001297) | 2.03457033 |
| 104 | Mutism (HP:0002300) | 2.02675944 |
| 105 | Megalencephaly (HP:0001355) | 2.01173593 |
| 106 | Sclerocornea (HP:0000647) | 2.01062430 |
| 107 | Abdominal situs inversus (HP:0003363) | 1.99908704 |
| 108 | Abnormality of abdominal situs (HP:0011620) | 1.99908704 |
| 109 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.99305909 |
| 110 | Papilledema (HP:0001085) | 1.98320087 |
| 111 | Oligodontia (HP:0000677) | 1.95033337 |
| 112 | Insidious onset (HP:0003587) | 1.94598692 |
| 113 | Termporal pattern (HP:0011008) | 1.94598692 |
| 114 | Spastic paraplegia (HP:0001258) | 1.93502966 |
| 115 | Dysautonomia (HP:0002459) | 1.92859369 |
| 116 | Nephrogenic diabetes insipidus (HP:0009806) | 1.90611346 |
| 117 | Persistence of primary teeth (HP:0006335) | 1.90381124 |
| 118 | Prolonged QT interval (HP:0001657) | 1.90259344 |
| 119 | Epileptiform EEG discharges (HP:0011182) | 1.89737218 |
| 120 | Failure to thrive in infancy (HP:0001531) | 1.89219806 |
| 121 | Overriding aorta (HP:0002623) | 1.88839408 |
| 122 | Vertigo (HP:0002321) | 1.88561226 |
| 123 | Acute lymphatic leukemia (HP:0006721) | 1.88465513 |
| 124 | Anxiety (HP:0000739) | 1.87438590 |
| 125 | Diminished motivation (HP:0000745) | 1.86992452 |
| 126 | Spastic gait (HP:0002064) | 1.86922192 |
| 127 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.85782930 |
| 128 | Tented upper lip vermilion (HP:0010804) | 1.85588735 |
| 129 | Submucous cleft hard palate (HP:0000176) | 1.83702901 |
| 130 | Memory impairment (HP:0002354) | 1.82573703 |
| 131 | Genetic anticipation (HP:0003743) | 1.82543323 |
| 132 | Abnormality of saccadic eye movements (HP:0000570) | 1.82194142 |
| 133 | Hemiparesis (HP:0001269) | 1.82129154 |
| 134 | Rhinitis (HP:0012384) | 1.82023865 |
| 135 | Paraplegia (HP:0010550) | 1.81899790 |
| 136 | Abnormality of salivation (HP:0100755) | 1.81295699 |
| 137 | Neurodegeneration (HP:0002180) | 1.80856946 |
| 138 | Ulnar claw (HP:0001178) | 1.80784991 |
| 139 | Progressive cerebellar ataxia (HP:0002073) | 1.80385272 |
| 140 | Growth hormone excess (HP:0000845) | 1.80271090 |
| 141 | Keratoconjunctivitis sicca (HP:0001097) | 1.79397272 |
| 142 | Autism (HP:0000717) | 1.79265299 |
| 143 | Agnosia (HP:0010524) | 1.78628183 |
| 144 | Methylmalonic aciduria (HP:0012120) | 1.76668699 |
| 145 | Athetosis (HP:0002305) | 1.75725957 |
| 146 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.75640815 |
| 147 | Abnormality of the columella (HP:0009929) | 1.75221260 |
| 148 | Recurrent bacterial skin infections (HP:0005406) | 1.72670413 |
| 149 | Onion bulb formation (HP:0003383) | 1.71550420 |
| 150 | Hypercortisolism (HP:0001578) | 1.70786585 |
| 151 | Hypsarrhythmia (HP:0002521) | 1.70702855 |
| 152 | EEG with generalized epileptiform discharges (HP:0011198) | 1.69784003 |
| 153 | Vasculitis (HP:0002633) | 1.69017700 |
| 154 | Intention tremor (HP:0002080) | 1.66936682 |
| 155 | Psychosis (HP:0000709) | 1.65514713 |
| 156 | Slow saccadic eye movements (HP:0000514) | 1.64224124 |
| 157 | Epiphyseal dysplasia (HP:0002656) | 1.62219771 |
| 158 | Limb ataxia (HP:0002070) | 1.59514743 |
| 159 | Increased IgE level (HP:0003212) | 1.58901332 |
| 160 | Ocular albinism (HP:0001107) | 1.57822888 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK1 | 7.13534614 |
| 2 | ARAF | 7.01132328 |
| 3 | PIM2 | 3.74375822 |
| 4 | IRAK3 | 3.51548017 |
| 5 | EPHA4 | 3.42815265 |
| 6 | BRAF | 2.71969455 |
| 7 | MAP3K14 | 2.35651453 |
| 8 | TAOK1 | 2.33998391 |
| 9 | PRKD3 | 2.30705236 |
| 10 | RAF1 | 2.28644748 |
| 11 | MARK1 | 2.25490858 |
| 12 | PRPF4B | 2.19229186 |
| 13 | MAP4K1 | 1.94503239 |
| 14 | TAOK2 | 1.93109449 |
| 15 | TYRO3 | 1.91431170 |
| 16 | MAP3K13 | 1.90782209 |
| 17 | TAOK3 | 1.83176693 |
| 18 | DDR2 | 1.77614183 |
| 19 | DAPK2 | 1.76954843 |
| 20 | CAMK1D | 1.71000565 |
| 21 | NTRK3 | 1.63100644 |
| 22 | ICK | 1.55687530 |
| 23 | MARK2 | 1.52976893 |
| 24 | MAP3K9 | 1.52332081 |
| 25 | MINK1 | 1.49203365 |
| 26 | NTRK2 | 1.49191370 |
| 27 | MAP2K7 | 1.47993840 |
| 28 | DMPK | 1.41674727 |
| 29 | MAP3K4 | 1.37932144 |
| 30 | CASK | 1.27787293 |
| 31 | IRAK4 | 1.24692065 |
| 32 | PRKCH | 1.23352071 |
| 33 | ERN1 | 1.22458313 |
| 34 | PLK3 | 1.19541531 |
| 35 | TNK2 | 1.19290000 |
| 36 | BCKDK | 1.15872312 |
| 37 | PAK6 | 1.13974186 |
| 38 | MAPK13 | 1.13081242 |
| 39 | IRAK2 | 1.12927190 |
| 40 | FGR | 1.10881855 |
| 41 | KSR1 | 1.09217644 |
| 42 | PINK1 | 1.05035400 |
| 43 | MATK | 1.01148046 |
| 44 | SIK2 | 0.99702469 |
| 45 | GRK5 | 0.96868679 |
| 46 | CAMKK1 | 0.96342822 |
| 47 | CDK5 | 0.91663997 |
| 48 | PLK2 | 0.89438295 |
| 49 | SYK | 0.86627650 |
| 50 | PDK1 | 0.86564590 |
| 51 | RPS6KA2 | 0.86071952 |
| 52 | TNIK | 0.85201573 |
| 53 | UHMK1 | 0.82411782 |
| 54 | TBK1 | 0.82057229 |
| 55 | CAMK2G | 0.81490706 |
| 56 | CAMKK2 | 0.80168951 |
| 57 | MAP3K11 | 0.80008985 |
| 58 | GRK6 | 0.79851990 |
| 59 | KSR2 | 0.79304650 |
| 60 | TXK | 0.79167876 |
| 61 | PHKG2 | 0.78808102 |
| 62 | PHKG1 | 0.78808102 |
| 63 | MAP2K4 | 0.78467424 |
| 64 | BMPR1B | 0.77732915 |
| 65 | PDGFRA | 0.76860460 |
| 66 | JAK3 | 0.74340399 |
| 67 | CSNK1A1L | 0.73712846 |
| 68 | CSNK1G2 | 0.73637960 |
| 69 | STK38 | 0.72744937 |
| 70 | ERBB3 | 0.72709003 |
| 71 | RIPK4 | 0.72629145 |
| 72 | IKBKE | 0.71727246 |
| 73 | CAMK2B | 0.71581526 |
| 74 | EEF2K | 0.71394416 |
| 75 | CSK | 0.70544887 |
| 76 | CAMK1G | 0.68911532 |
| 77 | MAPK12 | 0.66780611 |
| 78 | JAK2 | 0.66608779 |
| 79 | MAP2K6 | 0.65595500 |
| 80 | STK11 | 0.64119686 |
| 81 | DAPK1 | 0.63321072 |
| 82 | IKBKB | 0.63204036 |
| 83 | TRIB3 | 0.62579787 |
| 84 | FES | 0.62119425 |
| 85 | PDPK1 | 0.61386445 |
| 86 | BTK | 0.61239120 |
| 87 | CSNK1G3 | 0.58111687 |
| 88 | PNCK | 0.58067322 |
| 89 | CDC42BPA | 0.57182306 |
| 90 | CCNB1 | 0.56217907 |
| 91 | CDK12 | 0.54882103 |
| 92 | CSF1R | 0.54250070 |
| 93 | PRKCE | 0.52605573 |
| 94 | MAP3K3 | 0.50918494 |
| 95 | SIK3 | 0.50010039 |
| 96 | TYK2 | 0.49574182 |
| 97 | KIT | 0.49315149 |
| 98 | HCK | 0.48924832 |
| 99 | PIM1 | 0.46745976 |
| 100 | CHUK | 0.46338955 |
| 101 | PRKCI | 0.45769859 |
| 102 | CDK18 | 0.45276225 |
| 103 | JAK1 | 0.43763119 |
| 104 | HIPK2 | 0.42557221 |
| 105 | RPS6KA1 | 0.41315358 |
| 106 | FGFR2 | 0.40938602 |
| 107 | MAP3K6 | 0.40848617 |
| 108 | CDK15 | 0.40672314 |
| 109 | EPHB2 | 0.40665390 |
| 110 | SGK223 | 0.40403191 |
| 111 | SGK494 | 0.40403191 |
| 112 | MAP3K1 | 0.39981264 |
| 113 | MAP3K2 | 0.38962559 |
| 114 | ITK | 0.38881009 |
| 115 | CAMK2D | 0.38739116 |
| 116 | PRKCQ | 0.38081949 |
| 117 | TESK2 | 0.38048292 |
| 118 | MAP2K2 | 0.37687484 |
| 119 | MAPK4 | 0.37580871 |
| 120 | ZAP70 | 0.37566948 |
| 121 | CSNK1G1 | 0.36967442 |
| 122 | BMPR2 | 0.36955752 |
| 123 | NTRK1 | 0.36520846 |
| 124 | CDK14 | 0.35934035 |
| 125 | RPS6KA6 | 0.35892261 |
| 126 | FYN | 0.34394900 |
| 127 | LCK | 0.34083102 |
| 128 | PRKCZ | 0.33509170 |
| 129 | DAPK3 | 0.33140095 |
| 130 | MAPK9 | 0.33006619 |
| 131 | MAP2K3 | 0.32599643 |
| 132 | MAPK8 | 0.32524749 |
| 133 | PRKCG | 0.32372912 |
| 134 | PAK3 | 0.31171962 |
| 135 | PRKD2 | 0.30631234 |
| 136 | CDK11A | 0.30448827 |
| 137 | CAMK1 | 0.29999266 |
| 138 | SGK2 | 0.29738834 |
| 139 | CAMK2A | 0.29572741 |
| 140 | ZAK | 0.29367004 |
| 141 | MAPK10 | 0.29143921 |
| 142 | DYRK2 | 0.29098334 |
| 143 | RET | 0.29032526 |
| 144 | CAMK4 | 0.28995367 |
| 145 | ALK | 0.27970437 |
| 146 | RPS6KC1 | 0.26454307 |
| 147 | RPS6KL1 | 0.26454307 |
| 148 | PRKD1 | 0.26143748 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Olfactory transduction_Homo sapiens_hsa04740 | 5.56061568 |
| 2 | Morphine addiction_Homo sapiens_hsa05032 | 3.38749909 |
| 3 | Circadian entrainment_Homo sapiens_hsa04713 | 3.27791283 |
| 4 | GABAergic synapse_Homo sapiens_hsa04727 | 3.19847197 |
| 5 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.94888245 |
| 6 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.75187572 |
| 7 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.75152221 |
| 8 | Cholinergic synapse_Homo sapiens_hsa04725 | 2.61357318 |
| 9 | Serotonergic synapse_Homo sapiens_hsa04726 | 2.37993657 |
| 10 | Insulin secretion_Homo sapiens_hsa04911 | 2.37278110 |
| 11 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.23161159 |
| 12 | Nicotine addiction_Homo sapiens_hsa05033 | 2.06149994 |
| 13 | Phototransduction_Homo sapiens_hsa04744 | 1.95900433 |
| 14 | Taste transduction_Homo sapiens_hsa04742 | 1.88201031 |
| 15 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.77588226 |
| 16 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.65915418 |
| 17 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.64232164 |
| 18 | Long-term potentiation_Homo sapiens_hsa04720 | 1.63240715 |
| 19 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.61383025 |
| 20 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.59967233 |
| 21 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.54508415 |
| 22 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.54005675 |
| 23 | Cocaine addiction_Homo sapiens_hsa05030 | 1.52004454 |
| 24 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.50471445 |
| 25 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.44279582 |
| 26 | Alcoholism_Homo sapiens_hsa05034 | 1.42663042 |
| 27 | Endometrial cancer_Homo sapiens_hsa05213 | 1.38409620 |
| 28 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.38399854 |
| 29 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.35359958 |
| 30 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.34574561 |
| 31 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.31188611 |
| 32 | Salivary secretion_Homo sapiens_hsa04970 | 1.29574471 |
| 33 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.28288529 |
| 34 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.26990711 |
| 35 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.24650254 |
| 36 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.23039985 |
| 37 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.20444175 |
| 38 | Renin secretion_Homo sapiens_hsa04924 | 1.20428784 |
| 39 | Asthma_Homo sapiens_hsa05310 | 1.20220639 |
| 40 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.17633624 |
| 41 | Gap junction_Homo sapiens_hsa04540 | 1.17626964 |
| 42 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.16688307 |
| 43 | Leishmaniasis_Homo sapiens_hsa05140 | 1.14456679 |
| 44 | Ras signaling pathway_Homo sapiens_hsa04014 | 1.13296184 |
| 45 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.13100561 |
| 46 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.08632098 |
| 47 | Colorectal cancer_Homo sapiens_hsa05210 | 1.07013840 |
| 48 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.05505264 |
| 49 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.04052532 |
| 50 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.03905600 |
| 51 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.02454452 |
| 52 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.02262391 |
| 53 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.01389274 |
| 54 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.99525285 |
| 55 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.98573235 |
| 56 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.96323219 |
| 57 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.94966946 |
| 58 | Axon guidance_Homo sapiens_hsa04360 | 0.88718214 |
| 59 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.88265738 |
| 60 | Long-term depression_Homo sapiens_hsa04730 | 0.87738855 |
| 61 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.86484531 |
| 62 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.85935639 |
| 63 | Tight junction_Homo sapiens_hsa04530 | 0.85074544 |
| 64 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.85041027 |
| 65 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.83140114 |
| 66 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.80374902 |
| 67 | Hepatitis C_Homo sapiens_hsa05160 | 0.79237986 |
| 68 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.78746974 |
| 69 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.78482942 |
| 70 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.78108620 |
| 71 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.78100630 |
| 72 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.75865566 |
| 73 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.75775283 |
| 74 | Endocytosis_Homo sapiens_hsa04144 | 0.75513513 |
| 75 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.74926036 |
| 76 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.74060666 |
| 77 | Shigellosis_Homo sapiens_hsa05131 | 0.74007970 |
| 78 | Hepatitis B_Homo sapiens_hsa05161 | 0.72221893 |
| 79 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.70875486 |
| 80 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.70799270 |
| 81 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.69569568 |
| 82 | Melanogenesis_Homo sapiens_hsa04916 | 0.67503044 |
| 83 | Glioma_Homo sapiens_hsa05214 | 0.67389940 |
| 84 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.67079149 |
| 85 | Measles_Homo sapiens_hsa05162 | 0.65090575 |
| 86 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.63251510 |
| 87 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.62574850 |
| 88 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.62413029 |
| 89 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.61634127 |
| 90 | Salmonella infection_Homo sapiens_hsa05132 | 0.60517002 |
| 91 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.57615811 |
| 92 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.56786590 |
| 93 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.56273255 |
| 94 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.55887674 |
| 95 | Allograft rejection_Homo sapiens_hsa05330 | 0.55436763 |
| 96 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.53771736 |
| 97 | Influenza A_Homo sapiens_hsa05164 | 0.53600052 |
| 98 | Prion diseases_Homo sapiens_hsa05020 | 0.51821980 |
| 99 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.51728911 |
| 100 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.51144964 |
| 101 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.50842894 |
| 102 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.49581869 |
| 103 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.47963575 |
| 104 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.46900182 |
| 105 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.46720356 |
| 106 | Lysine degradation_Homo sapiens_hsa00310 | 0.46477563 |
| 107 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.45779113 |
| 108 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.45717439 |
| 109 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.45378155 |
| 110 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.44538142 |
| 111 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.43215693 |
| 112 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.40109693 |
| 113 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.37025102 |
| 114 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.36760483 |
| 115 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.36584568 |
| 116 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.36295463 |
| 117 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.36255025 |
| 118 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.35788872 |
| 119 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.35162564 |
| 120 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.34641287 |
| 121 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.34155336 |
| 122 | Pathways in cancer_Homo sapiens_hsa05200 | 0.32750086 |
| 123 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.30530403 |
| 124 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.29662385 |
| 125 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.27625002 |
| 126 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.26378532 |
| 127 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.25490592 |
| 128 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.24526449 |
| 129 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.24317305 |
| 130 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.23845125 |
| 131 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.22694808 |
| 132 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.21574132 |
| 133 | Tuberculosis_Homo sapiens_hsa05152 | 0.21545708 |
| 134 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.20476133 |
| 135 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.20428234 |
| 136 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.19314142 |
| 137 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.18632565 |
| 138 | Bile secretion_Homo sapiens_hsa04976 | 0.18191246 |

